Researchers at the University of Ottawa, in collaboration with Danilo Zia and Fabio Sciarrino from the Sapienza University of Rome, recently demonstrated a novel technique that allows the ...

Teplizumab, a humanized monoclonal antibody to CD3 on T cells, is approved by the Food and Drug Administration to delay the onset of clinical type 1 diabetes (stage 3) in patients 8 years of age or ...